XML 36 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on the Company’s financial statements amendment 1 - Amendment 1 [Member] - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2020
Jun. 30, 2020
Dec. 31, 2019
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Nov. 07, 2019
As Previously Reported in Form 10-K [Member]              
Condensed Financial Statements, Captions [Line Items]              
Warrant Liability
Common Stock Subject to Possible Redemption 126,056,624 125,957,664 125,680,303 125,871,358 125,781,370 125,680,303 115,562,660
Common Stock 382 383 382 383 384 382 401
Additional Paid-in Capital 4,521,796 4,620,755 4,898,117 4,707,061 4,797,048 4,898,117 5,000,221
Retained Earnings (Accumulated Deficit) $ 477,832 $ 378,866 101,502 292,558 202,578 101,502 (621)
Change in fair value of warrant liability        
Transaction costs allocable to warrant liability            
Net income (loss)     $ 101,502 $ 191,056 $ 101,076    
Weighted average shares outstanding, Common Stock subject to possible redemption (in Shares) 12,550,477 12,553,036 12,446,534 12,550,512 12,547,286    
Basic and diluted net income per share, Common Stock subject to possible redemption (in Dollars per share) $ 0.04 $ 0.04 $ 0.01 $ 0.05 $ 0.05    
Weighted average shares outstanding, Common Stock (in Shares) 3,821,463 3,818,918 3,305,465 3,821,429 3,824,645    
Basic and diluted net loss per share, Common Stock (in Dollars per share) $ (0.04) $ (0.07) $ 0.03 $ (0.10) $ (0.12)    
Net income (loss)       $ 191,056 $ 101,076 101,502  
Change in fair value of warrant liability        
Transaction costs associated with Initial Public Offering            
Initial classification of Common Stock subject to possible redemption           125,578,180  
Change in value of Common Stock subject to possible redemption       191,055 101,067 102,123  
Adjustments [Member]              
Condensed Financial Statements, Captions [Line Items]              
Warrant Liability $ 1,975,155 $ 1,975,155 $ 1,975,155 2,172,671 3,950,311 1,975,155 3,037,500
Common Stock Subject to Possible Redemption (1,975,155) (1,975,155) (1,975,155) (2,172,671) (3,950,311) (1,975,155) (3,037,500)
Common Stock 20 20 20 22 40 20 31
Additional Paid-in Capital (1,204,671) (1,204,671) (1,204,671) (1,007,157) 770,465 (1,204,671) 19,915
Retained Earnings (Accumulated Deficit) $ 1,204,651 $ 1,204,651 1,204,651 1,007,135 (770,505) 1,204,651 (19,946)
Change in fair value of warrant liability     1,224,597 (197,516) (1,975,156)    
Transaction costs allocable to warrant liability     (19,946)        
Net income (loss)     $ 1,204,651 $ (197,516) $ (1,975,156)    
Weighted average shares outstanding, Common Stock subject to possible redemption (in Shares) (197,240) (196,999) (318,172) (196,900) (201,796)    
Basic and diluted net income per share, Common Stock subject to possible redemption (in Dollars per share)    
Weighted average shares outstanding, Common Stock (in Shares) 197,240 196,986 88,564 196,899 201,805    
Basic and diluted net loss per share, Common Stock (in Dollars per share) $ 0.01 $ 0.30 $ (0.04) $ (0.48)    
Net income (loss)       $ (197,516) $ (1,975,156) 1,204,651  
Change in fair value of warrant liability       197,516 1,975,156 (1,224,597)  
Transaction costs associated with Initial Public Offering           19,946  
Initial classification of Common Stock subject to possible redemption           (3,199,752)  
Change in value of Common Stock subject to possible redemption       (197,516) (1,975,156) 1,224,597  
As Restated in Form 10-K Amendment 1 [Member]              
Condensed Financial Statements, Captions [Line Items]              
Warrant Liability $ 1,975,155 $ 1,975,155 $ 1,975,155 2,172,671 3,950,311 1,975,155 3,037,500
Common Stock Subject to Possible Redemption 124,081,469 123,982,509 123,705,148 123,698,687 121,831,059 123,705,148 112,525,160
Common Stock 402 403 402 405 424 402 432
Additional Paid-in Capital 3,317,125 3,416,084 3,693,446 3,699,904 5,567,513 3,693,446 5,020,136
Retained Earnings (Accumulated Deficit) $ 1,682,483 $ 1,583,517 1,306,153 1,299,693 (567,927) 1,306,153 $ (20,567)
Change in fair value of warrant liability     1,224,597 197,516 (1,975,156)    
Transaction costs allocable to warrant liability     (19,946)        
Net income (loss)     $ 1,306,153 $ (6,460) $ (1,874,080)    
Weighted average shares outstanding, Common Stock subject to possible redemption (in Shares) 12,353,237 12,356,037 12,128,362 12,353,612 12,345,490    
Basic and diluted net income per share, Common Stock subject to possible redemption (in Dollars per share) $ 0.04 $ 0.04 $ 0.01 $ 0.05 $ 0.05    
Weighted average shares outstanding, Common Stock (in Shares) 4,018,703 4,015,904 3,394,029 4,018,328 4,026,450    
Basic and diluted net loss per share, Common Stock (in Dollars per share) $ (0.04) $ (0.06) $ 0.33 $ (0.14) $ (0.60)    
Net income (loss)       $ (6,460) $ (1,874,080) 1,306,153  
Change in fair value of warrant liability       197,516 1,975,156 (1,224,597)  
Transaction costs associated with Initial Public Offering           19,946  
Initial classification of Common Stock subject to possible redemption           122,378,428  
Change in value of Common Stock subject to possible redemption       $ (6,461) $ (1,874,089) $ 1,326,720